Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2015 1
2016 1
2019 1
2020 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
The following term was not found in PubMed: /
Page 1
Randomized, controlled trial of fesoterodine fumarate for overactive bladder in Parkinson's disease.
Yonguc T, Sefik E, Inci I, Kusbeci OY, Celik S, Aydın ME, Polat S. Yonguc T, et al. World J Urol. 2020 Aug;38(8):2013-2019. doi: 10.1007/s00345-019-02981-7. Epub 2019 Oct 23. World J Urol. 2020. PMID: 31642953 Clinical Trial.
AIMS: To evaluate short-term efficacy and safety of fesoterodine fumarate in Parkinson's disease (PD) patients with overactive bladder (OAB) symptoms. ...Cognitive functions were stable after 4 weeks of fesoterodine 4 mg treatment. CONCLUSIONS: OAB symptoms w …
AIMS: To evaluate short-term efficacy and safety of fesoterodine fumarate in Parkinson's disease (PD) patients with overactive …
The short-term and long-term adverse ocular effects of fesoterodine fumarate.
Erginturk Acar D, Acar U, Ozdemir O, Ozen Tunay Z, Cavkaytar S. Erginturk Acar D, et al. Cutan Ocul Toxicol. 2016 Sep;35(3):181-4. doi: 10.3109/15569527.2015.1072547. Epub 2015 Aug 12. Cutan Ocul Toxicol. 2016. PMID: 26340514 Clinical Trial.
AIM: To evaluate the short-term and long-term effects of fesoterodine fumarate treatment which is used for overactive bladder (OAB) on pupil diameter (PD), intraocular pressure (IOP) and accommodation amplitude (AA). METHOD: Ophthalmic examination was performed befo …
AIM: To evaluate the short-term and long-term effects of fesoterodine fumarate treatment which is used for overactive bladder (OAB) o …
Treating neurogenic detrusor overactivity in order to manage autonomic dysreflexia - A systematic review.
Le BT, Denys P, Joussain C. Le BT, et al. Auton Neurosci. 2026 Oct;267:103454. doi: 10.1016/j.autneu.2026.103454. Epub 2026 Jul 8. Auton Neurosci. 2026. PMID: 42430939
No study evaluated augmentation cystoplasty. One study (12 patients) evaluating fesoterodine and four studies (95 patients) evaluating BTX injection demonstrated improved urodynamic parameters and a decrease in severity of AD during urodynamic studies and in daily life. Im …
No study evaluated augmentation cystoplasty. One study (12 patients) evaluating fesoterodine and four studies (95 patients) evaluatin …
Gateways to clinical trials.
Bayes M, Rabasseda X, Prous JR. Bayes M, et al. Methods Find Exp Clin Pharmacol. 2006 Jul-Aug;28(6):379-412. Methods Find Exp Clin Pharmacol. 2006. PMID: 16894408 Clinical Trial.
This issue focuses on the following selection of drugs:(R)-Flurbiprofen, 90Yttrium-DOTA-huJ591; ABT-510, ACP-103, Ad5-FGF4, adalimumab, ademetionine, AG-7352, alemtuzumab, Amb a 1 ISS-DNA, anakinra, apaziquone, aprepitant, aripiprazole, atazanavir sulfate; BAL-8557, bevacizumab, …
This issue focuses on the following selection of drugs:(R)-Flurbiprofen, 90Yttrium-DOTA-huJ591; ABT-510, ACP-103, Ad5-FGF4, adalimumab, adem …